Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
Sorafenib is a first-line treatment for patients with advanced hepatocellular carcinoma (HCC). These patients may simultaneously receive anti-hepatitis B treatment if they are viremic. The <i>N-Acetylgalactosaminyltransferase 14</i> (<i>GALNT14</i>) gene can serve as a biomar...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/561db4041fd940c886045ef37ad752e0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|